Sorry, you need to enable JavaScript to visit this website.
  • Branded drugs are more expensive because they’re newer, generally groundbreaking, and often for conditions that are difficult to treat. However, after a certain period of time, these same innovative medicines become generic medicines.

  • The difference between our approach and that of many other companies is that when a medicine becomes a generic, we still assume responsibility. Rather than focus on just what’s in development, we continue to closely monitor the quality, safety, and reliability of our generic medicines.

Purpose & Ideals

The Mindfulness of Medicine Development: How Scientists Are Driving the Next Wave of Medical Innovations

For millions of patients around the world, the development of a new treatment or vaccine can be life-changing.
Mindfulness of Medicine Development collage thumbnail
Programs & Initiatives

Bridging Global Gaps in Hemophilia Care

Pfizer is proud of its commitment to advancing hemophilia care for more than 40 years, dating back to the introduction of recombinant therapies.
Nurse tending to patient thumbnail image
Science & Innovation

The Next Era of Decentralized Clinical Trials: The Clinical Trial Anywhere Model

About Pfizer's initiative to make clinical trials more participant-friendly through the decentralized "Clinical Trial Anywhere" model; a suite of solutions like remote sample collection, alternative study conduct locations, home health, and mobile units to reduce the need for in-person visits.
Doctor showing medical data to patient on tablet thumbnail

The medicines available today have taken an average of 12 years to develop. With dedication, creativity, and science, we can significantly cut that time.

  • 00Phase 1
  • 00Phase 2
  • 00Phase 3
  • 00Registration
  • 00Total

Learn more about the process of joining a clinical trial and find a trial near you.

Go to Pfizer Clinical Trials Site Details